ReviewGut microbes

End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics.

Jason Goldsmith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.